European Society of Toxicology In Vitro > Uncategorized > ILSI survey on human tissue applications.
27 May 2024

ILSI survey on human tissue applications.

ILSI Europe is proud to contribute to ESTIV 2024 by actively engaging ESTIV members and followers in a questionnaire and short survey on human tissue applications. These resources, curated by the Expert Group on Human Tissue appointed by ILSI Europe’s Alternatives to Animal Testing Task Force, aim to foster engagement and ignite fresh perspectives. Your participation in both endeavours will enhance the discourse on this subject and drive us towards innovative solutions.

To take part in the short survey, click here.

To engage in the questionnaire, please follow the link below:

Alternatives to Animal Testing Task Force Human Tissues Expert Group
The Expert Group on Human Tissues from ILSI Europe, has developed a questionnaire to explore the viability of using human tissues as a replacement for animal testing. Go to thiss way

Please submit your responses by June 20, and feel free to share this content within your network.

Finally, don’t hesitate to register for ILSI’s upcoming webinars in Toxicological Hazard and Risk Assessment: Exploring Innovative Testing and NAMs

📝 To register, please click on the links below:

Webinar on 28 May | 14:00-16:00 CET: https://us06web.zoom.us/meeting/register/tZYuc-muqz0jGNwsHcUPEoYUDagWJ_sV9L_e

Webinar on 30 May | 14:00-16:00 CET:  https://us06web.zoom.us/meeting/register/tZwvfu6hqz8tGtDn1aZFhvKnrfgpv1xmUegE

Your ILSI Team

Related content

Fraudulent e-mails offering ESTIV Congress attendance lists – be cautious!

Be aware that there are fraudulent e-mails sent out by scammers offering the congress attendance lists, accommodation, services etc

ESTIV Best Abstract Award at the VHP 2026 Conference

The award, valued at €300, will recognise an outstanding abstract in the field of in silico toxicology and New Approach Methodologies (NAMs).

Special Issue completed – ESTIV 2024: The Application of New Approach Methodologies (NAMs) in Drug Discovery and Drug and Chemical Safety Assessment

  • News

ESTIV would like to extend its heartfelt thanks to all contributors to this special issue, which highlights some of the science and activities that took place during the congress.

Silver Sponsor

Communication partners

Memorandum of Understanding